Sylvia Schuepbach Sylvia Schuepbach

Compassionate Use

Early Access Program: Access to innovative medicines for patients

A pharmaceutical company with a focus on clinical research has implemented a compassionate use program at the request of the medical profession.

Learn More
Sylvia Schuepbach Sylvia Schuepbach

Experimental therapy

Swiss doctors have enquired with an international pharmaceutical company about the availability of a drug not approved in Switzerland for the treatment of a fatal disease as part of an experimental trial.

Learn More